AJJ Medtech Holdings Limited (SGX: 584)
Singapore
· Delayed Price · Currency is SGD 0.0030
0.00 (0.00%)
At close: Dec 20, 2024
AJJ Medtech Holdings Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Other Revenue | 2.54 | 1.62 | 0.6 | 0.32 | 0.68 | 0.21 | Upgrade
|
| Total Revenue | 2.54 | 1.62 | 0.6 | 0.32 | 0.68 | 0.21 | Upgrade
|
| Revenue Growth (YoY | 181.51% | 170.97% | 86.83% | -53.29% | 229.95% | -72.87% | Upgrade
|
| Property Expenses | 1.9 | 0.92 | 0.28 | 0.05 | - | - | Upgrade
|
| Selling, General & Administrative | 3.74 | 3.27 | 4.28 | 4.37 | 2.54 | 0.44 | Upgrade
|
| Other Operating Expenses | -0.18 | -0.02 | -0.08 | -0.18 | 0.92 | 0.72 | Upgrade
|
| Total Operating Expenses | 5.46 | 4.17 | 4.48 | 4.24 | 3.46 | 1.16 | Upgrade
|
| Operating Income | -2.93 | -2.55 | -3.88 | -3.92 | -2.78 | -0.95 | Upgrade
|
| Interest Expense | -0.06 | -0.06 | -0.06 | -0.08 | -0.1 | -0.11 | Upgrade
|
| EBT Excluding Unusual Items | -2.99 | -2.61 | -3.94 | -3.99 | -2.88 | -1.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 1.88 | - | - | Upgrade
|
| Asset Writedown | - | - | -0.05 | - | - | - | Upgrade
|
| Total Legal Settlements | 0.05 | 0.05 | - | 0.37 | - | - | Upgrade
|
| Other Unusual Items | 0.08 | 0 | 0.01 | - | 0.07 | - | Upgrade
|
| Pretax Income | -2.87 | -2.56 | -3.98 | -1.74 | -2.81 | -1.06 | Upgrade
|
| Income Tax Expense | -0.01 | -0.01 | -0.28 | -0 | -0 | -0.1 | Upgrade
|
| Earnings From Continuing Operations | -2.86 | -2.56 | -3.7 | -1.73 | -2.8 | -0.96 | Upgrade
|
| Earnings From Discontinued Operations | - | 0.03 | -0.54 | - | - | - | Upgrade
|
| Net Income to Company | -2.86 | -2.53 | -4.24 | -1.73 | -2.8 | -0.96 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0.04 | 0.03 | - | Upgrade
|
| Net Income | -2.86 | -2.53 | -4.24 | -1.7 | -2.77 | -0.96 | Upgrade
|
| Net Income to Common | -2.86 | -2.53 | -4.24 | -1.7 | -2.77 | -0.96 | Upgrade
|
| Basic Shares Outstanding | 1,224 | 934 | 934 | 934 | 770 | 668 | Upgrade
|
| Diluted Shares Outstanding | 1,224 | 934 | 934 | 934 | 770 | 668 | Upgrade
|
| Shares Change (YoY) | 31.12% | - | - | 21.32% | 15.18% | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Operating Margin | -115.50% | -158.08% | -651.17% | -1228.53% | -406.59% | -458.45% | Upgrade
|
| Profit Margin | -112.90% | -156.47% | -711.58% | -531.66% | -405.71% | -461.35% | Upgrade
|
| Free Cash Flow Margin | -51.95% | -110.53% | -537.42% | -1737.93% | -111.42% | -160.87% | Upgrade
|
| EBITDA | -2.76 | -2.37 | -3.64 | -3.74 | -2.38 | -0.61 | Upgrade
|
| EBITDA Margin | -108.68% | -147.00% | - | - | - | -294.69% | Upgrade
|
| D&A For Ebitda | 0.17 | 0.18 | 0.24 | 0.18 | 0.4 | 0.34 | Upgrade
|
| EBIT | -2.93 | -2.55 | -3.88 | -3.92 | -2.78 | -0.95 | Upgrade
|
| EBIT Margin | -115.50% | -158.08% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Real Estate template. Financial Sources.